申请人:American Cyanamid Company
公开号:US04447442A1
公开(公告)日:1984-05-08
This disclosure describes novel 3-substituted amino-1-phenyl-2-pyrazolines and 3-substituted amino-1-mono and disubstituted phenyl-2-pyrazolines and their C.sub.4 and C.sub.5 analogs, useful for meliorating the inflammation and/or the progressive joint deterioration characteristic of arthritic disease, preventing the onset of asthmatic symptoms and allergic diseases, or as analgesic, antibacterial or antifungal agents.
这份披露描述了新颖的3-取代氨基-1-苯基-2-吡唑烯和3-取代氨基-1-单取代和双取代苯基-2-吡唑烯及其C.sub.4和C.sub.5类似物,可用于改善关节炎疾病的炎症和/或进行性关节恶化特征,预防哮喘症状和过敏疾病的发作,或作为镇痛剂、抗菌剂或抗真菌剂。